Monthly Archives: February 2013

Bayer Fights Against Federal Multi-District Litigation Consolidation

Although Bayer petitioned the New Jersey courts to consolidate Mirena IUD cases, Bayer is now opposing consolidation in the federal courts. This latest battle began when plaintiff’s counsel filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) … Read More

Posted in Multidistrict Litigation |

Forecasting Lawsuits for Medtronic Medical Devices

Serious complaints are stemming from Medtronic Infuse bone graft patients. Although Medtronic sales spiked at $800 million as recently as 2011, it appears a litany of Medtronic lawsuits are poised to launch. Complications tied to Medtronic products are deadly. They’ve … Read More

Posted in Lawsuits |

Companies to Pay $688 from Cholesterol Drug Lawsuits

The third largest drug company, Merck, and fellow pharmaceutical partner, Scherling-Plough had agreed to pay out $688 million dollars to their investors after not coming forward with an unfavorable study of their top selling cholesterol drugs, Zetia and Vytorin. Upon … Read More

Posted in Lawsuits |

Yaz Lawsuits Increase after FDA enforces new label

The number of lawsuits leveled against the PMDD medication company Yaz has risen significantly after the Federal Drug Administration ordered the company to place a stronger warning label on their product in April of 2012. The stronger warning label states … Read More

Posted in Lawsuits |

Stryker Recall Costly for the Orthopedic Manufacturer

Stryker Corporation said on Wednesday that a hip implant recall that began in June of 2012 will cost up to $390 million for treatment, new surgeries, lawsuits and insurance payments. The company said that is has raised the low end … Read More

Posted in Lawsuits |